亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.

医学 细胞因子释放综合征 氟达拉滨 环磷酰胺 毒性 耐火材料(行星科学) 内科学 T细胞 化疗 嵌合抗原受体 胃肠病学 免疫学 免疫系统 物理 天体生物学
作者
Navin R. Pinto,Catherine Michelle Albert,Mallory R. Taylor,Ashley Lauren Wilson,Stephanie D. Rawlings-Rhea,Wenjun Huang,Kristy D Seidel,Prabha Narayanaswany,Vicky Wu,Christopher A. Brown,Nicholas Alexander Vitanza,Rimas J. Orentas,Rebecca Alice Gardner,Michael C. Jensen,Julie R. Park
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:40 (16_suppl): 10011-10011 被引量:28
标识
DOI:10.1200/jco.2022.40.16_suppl.10011
摘要

10011 Background: B7H3 (CD276) has limited expression in normal tissues and high cell-surface expression in pediatric solid malignancies providing rationale for immunologic therapeutic targeting. We present a first-in-human experience of B7H3 chimeric antigen receptor T cells (CAR-T) for children and young adults (CYA) with relapsed or refractory solid tumors (R/RST). Methods: CYA patients with R/RST were enrolled onto a Phase 1 trial (NCT04483778) to examine the safety of autologous T cells genetically modified to express scFV-IgG4hinge-CD28tm-4-1BB-zeta B7H3-specific CAR with the methotrexate resistance/selection cassette DHFRdm and the tracking/suicide construct EGFRt. All patients received lymphodepleting fludarabine and cyclophosphamide prior to infusion of cryopreserved CAR-T at the prescribed dose level. The maximal tolerated dose or biologically effective dose (BED) was determined based upon observed toxicity through day 28 from initial CAR-T infusion and using a 3+3 statistical design. Results: Sixteen subjects (age 11-24, median 17 years) enrolled and received dose level (DL) 1 (0.5 x 10 6 CAR-T/kg, n = 3) or DL2 (1 x 10 6 CAR-T cells/kg, n = 6). No dose limiting toxicity was observed following first infusion, most common toxicities were fatigue and cytokine release syndrome (CRS) (n = 2, maximum CTCAE grade 2). Maximum circulating CAR-T expansion on first infusion was 4.98 cells/uL (range 0.23-4.98 cells/uL) with median persistence of 28 days (range 14-90). Best overall response of Stable Disease was observed in 3 of the 9 subjects infused. Given observed expansion and persistence, DL2 was determined to be the BED. A second infusion at DL2 in one subject demonstrated CAR T expansion to 1590 cells/uL (86% of circulating CD3 cells) with CTCAE grade 2 CRS and transient dose limiting CTCAE grade 4 liver enzyme elevation. A partial metabolic response on FDG-PET by PERCIST criteria was observed in this subject at Day 28. Conclusions: B7H3 CAR T cells are safe and demonstrate anti-tumor activity in CYA with R/RST. CAR-T cell expansion and persistence may be necessary to achieve objective responses. STRIvE-02 Arm B will explore dual expression of CD19 CAR with B7H3 CAR, using lymphocytic CD19 expression to drive CAR expansion and persistence. Clinical trial information: NCT04483778.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
熊猫四海完成签到 ,获得积分10
9秒前
科研通AI6.4的应助被YCLING采纳,获得10
12秒前
玖嬴完成签到,获得积分10
15秒前
Owen的应助被北极幸运星采纳,获得20
16秒前
可靠之玉发布了新的文献求助30
18秒前
helloWorld完成签到,获得积分10
20秒前
21秒前
kiki发布了新的文献求助10
25秒前
26秒前
萧雨墨发布了新的文献求助10
28秒前
29秒前
33秒前
pang完成签到,获得积分10
36秒前
36秒前
努力学习中完成签到,获得积分10
37秒前
余香的应助被萧雨墨采纳,获得10
40秒前
45秒前
YCLING发布了新的文献求助10
45秒前
45秒前
infinity完成签到 ,获得积分10
45秒前
小蘑菇的应助被从容问柳采纳,获得100
46秒前
ubless607给成博的求助进行了留言
47秒前
666完成签到 ,获得积分10
47秒前
田様的应助被sissiarno采纳,获得10
48秒前
共享精神的应助被sissiarno采纳,获得10
48秒前
余香的应助被sissiarno采纳,获得10
48秒前
48秒前
嘻嘻哈哈的应助被sissiarno采纳,获得10
48秒前
Nole完成签到,获得积分0
48秒前
CipherSage的应助被sissiarno采纳,获得10
48秒前
完美世界的应助被sissiarno采纳,获得10
48秒前
ding的应助被sissiarno采纳,获得10
49秒前
完美世界的应助被sissiarno采纳,获得10
49秒前
脑洞疼的应助被sissiarno采纳,获得10
49秒前
的速度发布了新的文献求助10
50秒前
51秒前
53秒前
msezhj完成签到 ,获得积分10
53秒前
从容问柳发布了新的文献求助100
58秒前
ubless607举报成博的求助涉嫌违规
59秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190049
求助须知:如何正确求助?哪些是违规求助? 9577165
关于积分的说明 21851842
捐赠科研通 7788131
什么是DOI,文献DOI怎么找? 3436227
关于科研通互助平台的介绍 2559910
邀请新用户注册赠送积分活动 2482768